Phase I/II clinical trial of a genetically modified and oncolytic vaccinia virus GL-ONC1 in patients with unresactable, chemotherapy-resistant peritoneal carcinomatosis.
暂无分享，去创建一个
F. Fend | A. Szalay | U. Lauer | J. Sturm | M. Bitzer | A. Koenigsrainer | M. Zimmermann | C. Pfannenberg | N. Malek | J. Glatzle | U. Koppenhoefer | T. Auth | T. Yu | R. Moehle | Tony Yu | Julia B. Sturm